Correlation Between Trevi Therapeutics and Eliem Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Trevi Therapeutics and Eliem Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Trevi Therapeutics and Eliem Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Trevi Therapeutics and Eliem Therapeutics, you can compare the effects of market volatilities on Trevi Therapeutics and Eliem Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Trevi Therapeutics with a short position of Eliem Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Trevi Therapeutics and Eliem Therapeutics.

Diversification Opportunities for Trevi Therapeutics and Eliem Therapeutics

0.74
  Correlation Coefficient

Poor diversification

The 3 months correlation between Trevi and Eliem is 0.74. Overlapping area represents the amount of risk that can be diversified away by holding Trevi Therapeutics and Eliem Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eliem Therapeutics and Trevi Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Trevi Therapeutics are associated (or correlated) with Eliem Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eliem Therapeutics has no effect on the direction of Trevi Therapeutics i.e., Trevi Therapeutics and Eliem Therapeutics go up and down completely randomly.

Pair Corralation between Trevi Therapeutics and Eliem Therapeutics

Given the investment horizon of 90 days Trevi Therapeutics is expected to generate 0.79 times more return on investment than Eliem Therapeutics. However, Trevi Therapeutics is 1.26 times less risky than Eliem Therapeutics. It trades about 0.06 of its potential returns per unit of risk. Eliem Therapeutics is currently generating about 0.04 per unit of risk. If you would invest  185.00  in Trevi Therapeutics on September 14, 2024 and sell it today you would earn a total of  240.50  from holding Trevi Therapeutics or generate 130.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy98.79%
ValuesDaily Returns

Trevi Therapeutics  vs.  Eliem Therapeutics

 Performance 
       Timeline  
Trevi Therapeutics 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Trevi Therapeutics are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite fairly unsteady basic indicators, Trevi Therapeutics demonstrated solid returns over the last few months and may actually be approaching a breakup point.
Eliem Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Eliem Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Trevi Therapeutics and Eliem Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Trevi Therapeutics and Eliem Therapeutics

The main advantage of trading using opposite Trevi Therapeutics and Eliem Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Trevi Therapeutics position performs unexpectedly, Eliem Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eliem Therapeutics will offset losses from the drop in Eliem Therapeutics' long position.
The idea behind Trevi Therapeutics and Eliem Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Other Complementary Tools

Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes